ISDA

Entry Detail

PDB ID:

3BEL

Keywords:

TRANSFERASE

Title:

X-ray structure of EGFR in complex with oxime inhibitor

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Spodoptera frugiperda

PDB Version:

Deposition Date:

2007-11-19

Release Date:

2008-07-01

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.28

R-Value Work:

0.24

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Epidermal growth factor receptor
Chain IDs:A
Chain Length:315
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P00533 Pfam ID:PF07714 EC:2.7.10.1

Ligand Molecules

PO4

POX

Primary Citation

Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases.

Xu, G, Searle, L.L, Hughes, T.V, Beck, A.K, Connolly, P.J, Abad, M.C, Neeper, M.P, Struble, G.T, Springer, B.A, Emanuel, S.L, Gruninger, R.H, Pandey, N, Adams, M, Moreno-Mazza, S, Fuentes-Pesquera, A.R, Middleton, S.A, Greenberger, L.M.Show

Bioorg.Med.Chem.Lett. 18 3495 3499 (2008)

PMID: 18508264 DOI: 10.1016/j.bmcl.2008.05.024

Abstact

We herein disclose a novel series of 4-aminopyrimidine-5-carbaldehyde oximes that are potent and selective inhibitors of both EGFR and ErbB-2 tyrosine kinases, with IC(50) values in the nanomolar range. Structure-activity relationship (SAR) studies elucidated a critical role for the 4-amino and C-6 arylamino moieties. The X-ray co-crystal structure of EGFR with 37 was determined and validated our design rationale.

Legend

Protein

Chemical

Disease

Primary Citation of related structures